[Federal Register Volume 82, Number 20 (Wednesday, February 1, 2017)]
[Notices]
[Page 8944]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02156]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the 
President's Cancer Panel.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: President's Cancer Panel, ``Pricing and 
Payment Strategies for Cancer Drugs: Maximizing Patients' Access to 
Beneficial Therapies''.
    Date: March 27, 2017.
    Time: 8:30 a.m. to 4:00 p.m.
    Agenda: Welcome and Introductions; Opening Presentations; The 
Pricing Landscape; Public Comment; Potential Actions To Encourage 
Pricing Strategies That Maximize Patients' Access to Drug Therapy; 
The Payment Landscape; Wrap-Up and Final Remarks for the Day; Public 
Comment.
    Place: Kimpton Hotel Palomar, 117 South 17th Street, 
Philadelphia, PA 19103.
    Date: March 28, 2017.
    Time: 9:00 a.m. to 1:00 p.m.
    Agenda: Welcome and Introductions; Day 1 Recap and Continuing 
Discussion on The Payment Landscape; Potential Actions To Encourage 
Payment Strategies That Maximize Patients' Access to Drug Therapy; 
Conclusions and Cross-Cutting Recommendations; Wrap-Up and Next 
Steps; Public Comment.
    Place: Kimpton Hotel Palomar, 117 South 17th Street, 
Philadelphia, PA 19103.
    Contact Person: Abby B. Sandler, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, Rare 
Tumors Initiative, Center for Cancer Research, National Cancer 
Institute, NIH, 9000 Rockville Pike, Building 31, Room B2B37, MSC 
2590, Bethesda, MD 20892-8349, 301-451-9399, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://prescancerpanel.cancer.gov/, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 26, 2017.
Melanie J. Pantoja,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02156 Filed 1-31-17; 8:45 am]
 BILLING CODE 4140-01-P